Clinical Trials Logo

Clinical Trial Summary

Retinal thickness measurement is one of the most important examinations in the follow up of exudative age-related macular degeneration. Prior studies have shown that there are a series of algorithm line failures in OCT examinations. This study is conducted to compare the quality of the examinations of to different spectral domain OCT machines concerning the positioning of algorithm lines. Furthermore the reproducibility of the examinations id tested, both machines provide different techniques to guarantee that in repeated examinations the same location is examined.


Clinical Trial Description

n/a


Study Design

Observational Model: Cohort, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT00927303
Study type Observational
Source The Ludwig Boltzmann Institute of Retinology and Biomicroscopic Laser Surgery
Contact
Status Completed
Phase N/A
Start date July 2009
Completion date December 2009

See also
  Status Clinical Trial Phase
Completed NCT03071055 - Efficacy of Biweekly Ranibizumab (0.5 mg) for Exudative Macular Degeneration Retinal Edema Refractory to Anti-VEGF Phase 2
Withdrawn NCT04075136 - Optical Coherence Tomography Angiography (OCTA) - Directed PDT Triple Therapy Phase 4
Completed NCT04723160 - Computer Aided Diagnosis of Multiple Eye Fundus Diseases From Color Fundus Photograph
Completed NCT02732899 - Sirolimus in Conjunction With Eylea vs Eylea Alone for Exudative AMD Phase 2